TY  - JOUR
AU  - Sasamoto, Naoko
AU  - Babic, Ana
AU  - Rosner, Bernard A
AU  - Fortner, Renée T
AU  - Vitonis, Allison F
AU  - Yamamoto, Hidemi
AU  - Fichorova, Raina N
AU  - Tjønneland, Anne
AU  - Hansen, Louise
AU  - Overvad, Kim
AU  - Kvaskoff, Marina
AU  - Fournier, Agnès
AU  - Romana Mancini, Francesca
AU  - Boeing, Heiner
AU  - Trichopoulou, Antonia
AU  - Peppa, Eleni
AU  - Karakatsani, Anna
AU  - Palli, Domenico
AU  - Pala, Valeria
AU  - Mattiello, Amalia
AU  - Tumino, Rosario
AU  - Grasso, Chiara C
AU  - Onland-Moret, N Charlotte
AU  - Weiderpass, Elisabete
AU  - Quirós, J Ramón
AU  - Lujan-Barroso, Leila
AU  - Rodriguez-Barranco, Miguel
AU  - Colorado-Yohar, Sandra
AU  - Barricarte, Aurelio
AU  - Dorronsoro, Miren
AU  - Idahl, Annika
AU  - Lundin, Eva
AU  - Sartor, Hanna
AU  - Khaw, Kay-Tee
AU  - Key, Timothy J
AU  - Muller, David
AU  - Riboli, Elio
AU  - Gunter, Marc J
AU  - Dossus, Laure
AU  - Kaaks, Rudolf
AU  - Cramer, Daniel W
AU  - Tworoger, Shelley S
AU  - Terry, Kathryn L
PY  - 2019
DO  - 10.1158/1055-9965.EPI-18-1120
UR  - http://hdl.handle.net/10668/13790
T2  - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
AB  - Cancer antigen 125 (CA125) is the most promising ovarian cancer screening biomarker to date. Multiple studies reported CA125 levels vary by personal characteristics, which could inform personalized CA125 thresholds. However, this has not been well...
LA  - en
PB  - American Association for Cancer Research
KW  - Adult
KW  - CA-125 Antigen
KW  - Case-Control Studies
KW  - Early Detection of Cancer
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Membrane Proteins
KW  - Middle Aged
KW  - Ovarian Neoplasms
KW  - Premenopause
KW  - Prognosis
KW  - Prospective Studies
KW  - Women's Health
TI  - Predicting Circulating CA125 Levels among Healthy Premenopausal Women.
TY  - research article
VL  - 28
ER  -